Eli Lilly and Company (LLY)

NYSE - NYSE Real Time Price. Currency in USD
74.03-2.13 (-2.80%)
As of 11:56 AM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close76.16
Bid74.25 x 100
Ask74.26 x 400
Day's Range73.95 - 75.68
52wk Range67.88 - 88.16
1y Target EstN/A
Market Cap78.12B
P/E Ratio (ttm)32.20
Avg Vol (3m)3,482,181
Dividend & Yield2.04 (2.66%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Pharma Stock Roundup: Bristol-Myers, Merck Top Estimates, Merck Wins Key FDA Nod
    Zacks3 hours ago

    Pharma Stock Roundup: Bristol-Myers, Merck Top Estimates, Merck Wins Key FDA Nod

    Third quarter earnings season is in full flow with several companies like Lilly (LLY), Merck, Bristol-Myers, Novartis and others reporting results this week.

  • Reuters5 hours ago

    Biotech's election-year political cloud threatens to linger

    The long, dark tunnel that has been the U.S. presidential election campaign for biotechnology stocks appears to have no bright light beckoning the sector's beleaguered shareholders to a welcoming end. With the race winding down and most national opinion polls predicting victory for Democrat Hillary Clinton over Republican Donald Trump and probable gains for other Democrats in Congress, biotech shares are once again on the back foot, and investors say prospects for a sustained recovery look dim. Clinton, whose pointed criticisms of drug pricing have weighed on the industry for more than a year, has promised tougher oversight, and any big gains for her party on Capitol Hill would only strengthen her hand in that cause.

  • Capital Cube22 hours ago

    ETF’s with exposure to Eli Lilly & Co. : October 27, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Eli Lilly & Co. Here are 5 ETF’s with the largest exposure to LLY-US. Comparing the performance and risk of Eli Lilly & Co. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)